1. Home
  2. CGNX vs QGEN Comparison

CGNX vs QGEN Comparison

Compare CGNX & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cognex Corporation

CGNX

Cognex Corporation

N/A

Current Price

$63.68

Market Cap

10.7B

Sector

Industrials

ML Signal

N/A

Logo Qiagen N.V.

QGEN

Qiagen N.V.

N/A

Current Price

$43.92

Market Cap

8.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CGNX
QGEN
Founded
1981
1986
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
8.7B
IPO Year
1994
1998

Fundamental Metrics

Financial Performance
Metric
CGNX
QGEN
Price
$63.68
$43.92
Analyst Decision
Buy
Buy
Analyst Count
11
8
Target Price
$57.91
$45.76
AVG Volume (30 Days)
1.9M
2.2M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
0.64%
7.17%
EPS Growth
9.68
N/A
EPS
0.74
N/A
Revenue
N/A
N/A
Revenue This Year
$9.52
$8.18
Revenue Next Year
$8.63
$5.71
P/E Ratio
$90.39
$24.01
Revenue Growth
N/A
N/A
52 Week Low
$34.60
$32.53
52 Week High
$72.88
$57.82

Technical Indicators

Market Signals
Indicator
CGNX
QGEN
Relative Strength Index (RSI) 50.36 61.05
Support Level $62.63 $39.08
Resistance Level $70.53 $42.33
Average True Range (ATR) 2.84 0.85
MACD 0.47 -0.07
Stochastic Oscillator 52.61 89.09

Price Performance

Historical Comparison
CGNX
QGEN

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. Geographically, it operates in United states, Europe, Greater China and others. Cognex generates the maximum proportion of its sales in the United States and Europe.

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).

Share on Social Networks: